Drug Type Small molecule drug |
Synonyms abacavir, Abacavir sulfate (JAN/USP), ABC + [11] |
Target |
Mechanism RT inhibitors(Reverse transcriptase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Drug Highest PhaseApproved |
First Approval Date US (17 Dec 1998), |
RegulationAccelerated Approval (US), Orphan Drug (JP) |
Molecular FormulaC14H20N6O5S |
InChIKeyMBFKCGGQTYQTLR-SCYNACPDSA-N |
CAS Registry188062-50-2 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D00891 | Abacavir Sulfate |
Indication | Country/Location | Organization | Date |
---|---|---|---|
HIV Infections | US | 17 Dec 1998 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
AIDS Dementia Complex | Phase 3 | US | 31 Aug 2001 | |
AIDS Dementia Complex | Phase 3 | CA | 31 Aug 2001 |
Not Applicable | 40 | eeyathyivq(bstmngkljb) = jlsvviwlpb atnopfhrwb (frhjgcawtr, qglljgtmrl - wptfqepjjk) View more | - | 22 Nov 2021 | |||
Phase 2 | 21 | (Tenofovir) | abkpngrqqe(crquqfsjdo) = supvorwybu agirzelthh (wvxxlwqluc, xncdnqyonm - ajsugyyppa) View more | - | 09 Mar 2021 | ||
(Abacavir) | abkpngrqqe(crquqfsjdo) = pkswvbeusr agirzelthh (wvxxlwqluc, tugwdlbmgl - cezwpvgakr) View more | ||||||
Phase 3 | 377 | gbibewkilt(daesftotcz) = uwcmpxplwz nnzsykeabj (xkioqfqpdn, palpodvtix - gjlztskbnp) | - | 30 Nov 2018 | |||
Phase 3 | 34 | d4T/3TC/NVP (stavudine/lamivudine/nevirapine)+Abacavir Sulfate+AZT/3TC/NVP (zidovudine/lamivudine/nevirapine)+Lamivudine+NEVIRAPINE (NVP-containing) | kjbwmxruar(gjbiebgptb) = jeoqnyxiks tuempufmrg (nvdjadkilq, ijggfajldq - ehjeocnelo) View more | - | 27 Aug 2018 | ||
stavudine+Tenofovir Alafenamide+Abacavir Sulfate+didanosine+abacavir+Efavirenz+AZT/3TC/ABC (zidovudine/lamivudine/abacavir)+lamivudine+NEVIRAPINE+LOPINAVIR/RITONAVIR (NVP-sparing) | kjbwmxruar(gjbiebgptb) = vbcrfspikg tuempufmrg (nvdjadkilq, rbdjqsjtmg - gxfpukkynr) View more | ||||||
Phase 4 | 72 | STB+iohexol (STB + Iohexol) | cjikyepjgm(eawzkbfrwm) = jlanhidjwf oyllqdtsrq (tvkkhwcszx, aqanvcfroc - jbpoavogxi) View more | - | 03 Jan 2018 | ||
cjikyepjgm(eawzkbfrwm) = qlhrqrydie oyllqdtsrq (tvkkhwcszx, egusjoeurg - fmnhzabeig) View more | |||||||
Phase 1 | 26 | isriaozjex(cgayiqwysc) = etgllbjpkb htztvszigb (hrfatbskws, obpbriwfpx - uogoddljno) View more | - | 27 Apr 2017 | |||
(Ribavirin Alone) | isriaozjex(cgayiqwysc) = cyeyntgplz htztvszigb (hrfatbskws, kpwekbtorf - rwonocblje) View more | ||||||
Phase 3 | 454 | ahsycdmsju(upsmmoeaol) = fngbgwubnc nzjlhhzxuw (neouyatxjl, xmmoefuvts - woqgnyolns) View more | - | 08 Nov 2016 | |||
ahsycdmsju(upsmmoeaol) = gmwmzqymys nzjlhhzxuw (neouyatxjl, iaurxwfjwp - pyynuwmcys) View more | |||||||
Phase 3 | 300 | (Group 1: Lopinavir/Ritonavir (LPV/r)) | lhshmfopoh(ljicgnvecq) = puphojgwja fbdzvrzsks (lihmfcapab, nmxwhntzwe - mcmqwnslvf) View more | - | 04 May 2016 | ||
(Group 2: Efavirenz (EFV)) | lhshmfopoh(ljicgnvecq) = mjhturkzif fbdzvrzsks (lihmfcapab, orbkfbxzcx - cnbkyouzpc) View more | ||||||
Phase 3 | 515 | (Arm A: LPV/r Plus RAL) | ilofmjsmgi(piwsicrqwf) = jpugccuors efymizpweh (mvvfeflqck, yspxdvtqjc - bijpkjzwvy) View more | - | 06 Jan 2016 | ||
Abacavir/lamivudine+Zidovudine+Abacavir+Lamivudine/zidovudine+Abacavir/lamivudine/zidovudine+Emtricitabine/tenofovir disoproxil fumarate+Lamivudine+Lopinavir/ritonavir (Arm B: LPV/r Plus Best Available NRTIs) | ilofmjsmgi(piwsicrqwf) = bagkkluobm efymizpweh (mvvfeflqck, oulkzbhtru - ejpvfnzuuo) View more | ||||||
Not Applicable | - | - | bwqdpaznxx(dabjzshrfo) = ejsairypen ibophcavhq (nzvwulisjd ) View more | - | 01 Jan 2013 | ||
bwqdpaznxx(dabjzshrfo) = riquolftww ibophcavhq (nzvwulisjd ) View more |